Coated pharmaceutical packages are disclosed. In embodiments, a coated pharmaceutical package includes a glass body comprising a first surface. A low-friction coating may be positioned on at least a portion of the first surface of the glass body. The low-friction coating may include a polymer chemic
Coated pharmaceutical packages are disclosed. In embodiments, a coated pharmaceutical package includes a glass body comprising a first surface. A low-friction coating may be positioned on at least a portion of the first surface of the glass body. The low-friction coating may include a polymer chemical composition. A light transmission through the coated pharmaceutical package may be greater than or equal to about 55% of a light transmission through an uncoated pharmaceutical package for wavelengths from about 400 nm to about 700 nm. The low-friction coating may have a mass loss of less than about 5% of its mass when heated from a temperature of 150° C. to 350° C. at a ramp rate of about 10° C./minute.
대표청구항▼
1. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; anda l
1. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising: a polymer selected from the group consisting of polyimides, fluoropolymers, silsesquioxane-based polymers, and silicone resins; anda coupling agent layer disposed between the polymer and the first surface of the glass body,wherein the coefficient of friction of the portion of the coated pharmaceutical package with the low-friction coating is at least 20% less than a coefficient of friction of a surface of an uncoated pharmaceutical package formed from the same glass composition. 2. The coated pharmaceutical package of claim 1, wherein a thickness of the low friction coating is less than or equal to 1 μm. 3. The coated pharmaceutical package of claim 1, wherein a thickness of the low friction coating is less than or equal to 100 nm. 4. The coated pharmaceutical package of claim 1, wherein the coupling agent layer comprises a coupling agent; andwherein the low-friction coating comprises a polymer layer positioned over the coupling agent layer, the polymer layer comprising the polymer. 5. The coated pharmaceutical package of claim 4, wherein the coupling agent comprises at least one of: a first silane, a hydrolysate thereof, or an oligomer thereof; ora chemical formed from the oligomerization of at least the first silane and a second silane, wherein the first silane and the second silane are different. 6. The coated pharmaceutical package of claim 5, wherein the first silane is an aromatic silane. 7. The coated pharmaceutical package of claim 1, wherein the coupling agent layer comprises a silsesquioxane comprising an aromatic moiety and an amine moiety. 8. The coated pharmaceutical package of claim 1, wherein the coupling agent layer comprises at least one of: a mixture of a first silane and a second silane; ora chemical formed from the oligomerization of at least the first silane and the second silane, wherein the first silane and the second silane are different. 9. The coated pharmaceutical package of claim 8, wherein the first silane is an aromatic silane. 10. The coated pharmaceutical package of claim 1, wherein the polymer is a polyimide. 11. The coated pharmaceutical package of claim 1, wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 12. The coated pharmaceutical package of claim 1, wherein the glass body comprises ion-exchanged glass. 13. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising: a polymer selected from the group consisting of polyimides, fluoropolymers, silsesquioxane-based polymers, and silicone resins; anda coupling agent comprising at least one of: a first silane, a hydrolysate thereof, or an oligomer thereof, wherein the first silane is an aromatic silane; ora chemical formed from the oligomerization of at least the first silane and a second silane, wherein: the first silane and the second silane are different;a light transmission through the coated pharmaceutical package is greater than or equal to about 55% of a light transmission through an uncoated pharmaceutical package for wavelengths from about 400 nm to about 700 nm; andthe low-friction coating has a mass loss of less than about 5% of its mass when heated from a temperature of 150° C. to 350° C. at a ramp rate of about 10° C./minute. 14. The coated pharmaceutical package of claim 13, wherein a thickness of the low friction coating is less than or equal to 1 μm. 15. The coated pharmaceutical package of claim 13, wherein a thickness of the low friction coating is less than or equal to 100 nm. 16. The coated pharmaceutical package of claim 13, wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body, the coupling agent layer comprising the coupling agent; anda polymer layer positioned over the coupling agent layer, the polymer layer comprising the polymer. 17. The coated pharmaceutical package of claim 13, wherein the first silane is selected from the group consisting of aminophenyl alkoxysilanes, aminophenyl acyloxysilanes, aminophenyl halosilanes, 3-(m-aminophenoxy)propyl alkoxysilanes, 3-(m-aminophenoxy)propyl acyloxysilanes, 3-(m-aminophenoxy)propyl halosilanes, N-phenylaminopropyl alkoxysilanes, N-phenylaminopropyl acyloxysilanes, N-phenylaminopropyl halosilanes, (chloromethyl)phenyl alkoxysilanes, (chloromethyl)phenyl acyloxysilanes, and (chloromethyl)phenyl halosilanes. 18. The coated pharmaceutical package of claim 13, wherein the coupling agent comprises at least one of: a mixture of the first silane and the second silane, wherein the second silane is an aliphatic silane; ora chemical formed from the oligomerization of at least the first silane and the second silane. 19. The coated pharmaceutical package of claim 18, wherein a molar ratio of the first silane to the second silane is from about 0.1:1 to about 10:1. 20. The coated pharmaceutical package of claim 18, wherein the first silane is an aromatic alkoxysilane comprising at least one amine moiety and the second silane is an aliphatic alkoxysilane comprising at least one amine moiety. 21. The coated pharmaceutical package of claim 18, wherein the first silane is selected from the group consisting of aminophenyl alkoxysilanes, aminophenyl acyloxysilanes, aminophenyl halosilanes, 3-(m-aminophenoxy)propyl alkoxysilanes, 3-(m-aminophenoxy)propyl acyloxysilanes, 3-(m-aminophenoxy)propyl halosilanes, N-phenylaminopropyl alkoxysilanes, N-phenylaminopropyl acyloxysilanes, N-phenylaminopropyl halosilanes, (chloromethyl)phenyl alkoxysilanes, (chloromethyl)phenyl acyloxysilanes, (chloromethyl)phenyl halosilanes, hydrolysates thereof, and oligomers thereof, and the second silane is selected from the group consisting of aminophenyl alkoxysilanes, aminophenyl acyloxysilanes, aminophenyl halosilanes, 3-(m-aminophenoxy)propyl alkoxysilanes, 3-(m-aminophenoxy)propyl acyloxysilanes, 3-(m-aminophenoxy)propyl halosilanes, N-phenylaminopropyl alkoxysilanes, N-phenylaminopropyl acyloxysilanes, N-phenylaminopropyl halosilanes, (chloromethyl)phenyl alkoxysilanes, (chloromethyl)phenyl acyloxysilanes, (chloromethyl)phenyl halosilanes, hydrolysates thereof, and oligomers thereof. 22. The coated pharmaceutical package of claim 18, wherein the first silane comprises at least one amine moiety and the second silane comprises at least one amine moiety. 23. The coated pharmaceutical package of claim 18, wherein the first silane is aminophenyltrimethoxy silane and the second silane is 3-aminopropyltrimethoxy silane. 24. The coated pharmaceutical package of claim 13, wherein the polymer is a polyimide formed from the polymerization of: at least one monomer comprising at least two amine moieties; andat least one monomer comprising at least two anhydride moieties and having a benzophenone structure. 25. The coated pharmaceutical package of claim 24, wherein the at least one monomer comprises at least two anhydride moieties is benzophenone-3,3′,4,4′-tetracarboxylic dianhydride. 26. The coated pharmaceutical package of claim 13, wherein the polymer is a polyimide formed from the polymerization of at least: a first monomer, the first monomer comprising at least two amine moieties;a second monomer, the second monomer comprising at least two amine moieties; anda third monomer, the third monomer comprising at least two anhydride moieties; wherein the first monomer is different than the second monomer. 27. The coated pharmaceutical package of claim 13, wherein the glass body is formed from a borosilicate glass composition. 28. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a polymer, wherein: a light transmission through the coated pharmaceutical package is greater than or equal to about 55% of a light transmission through an uncoated pharmaceutical package for wavelengths from about 400 nm to about 700 nm; andthe low-friction coating has a mass loss of less than about 5% of its mass when heated from a temperature of 150° C. to 350° C. at a ramp rate of about 10° C./minute, wherein the polymer is a polyimide. 29. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising: a polymer selected from the group consisting of polyimides, fluoropolymers, silsesquioxane-based polymers, and silicone resins; anda coupling agent layer disposed between the polymer and the first surface of the glass body, wherein the coefficient of friction of the portion of the coated pharmaceutical package with the low-friction coating is at least 20% less than a coefficient of friction of a surface of an uncoated pharmaceutical package formed from the same glass composition. 30. The coated pharmaceutical package of claim 29, wherein a thickness of the low friction coating is less than or equal to 1 μm. 31. The coated pharmaceutical package of claim 29, wherein a thickness of the low friction coating is less than or equal to 100 nm. 32. The coated pharmaceutical package of claim 29, wherein the coupling agent layer comprises a coupling agent. 33. The coated pharmaceutical package of claim 32, wherein the coupling agent layer is positioned on the first surface of the glass body, the coupling agent layer comprising the coupling agent; anda polymer layer positioned over the coupling agent layer, the polymer layer comprising the polymer. 34. The coated pharmaceutical package of claim 33, wherein the coupling agent comprises at least one of: a first silane, a hydrolysate thereof, or an oligomer thereof; ora chemical formed from the oligomerization of at least the first silane and a second silane, wherein the first silane and the second silane are different. 35. The coated pharmaceutical package of claim 34, wherein the first silane is an aromatic silane. 36. The coated pharmaceutical package of claim 32, wherein the coupling agent comprises a silsesquioxane comprising an aromatic moiety and an amine moiety. 37. The coated pharmaceutical package of claim 32, wherein the coupling agent comprises at least one of: a mixture of a first silane and a second silane; ora chemical formed from the oligomerization of at least the first silane and the second silane, wherein the first silane and the second silane are different. 38. The coated pharmaceutical package of claim 37, wherein the first silane is an aromatic silane. 39. The coated pharmaceutical package of claim 29, wherein the polymer is a polyimide. 40. The coated pharmaceutical package of claim 29, wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 41. The coated pharmaceutical package of claim 29, wherein the glass body comprises ion-exchanged glass. 42. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a polymer, wherein: a light transmission through the coated pharmaceutical package is greater than or equal to about 55% of a light transmission through an uncoated pharmaceutical package for wavelengths from about 400 nm to about 700 nm; andthe low-friction coating has a mass loss of less than about 5% of its mass when heated from a temperature of 150° C. to 350° C. at a ramp rate of about 10° C./minute, wherein the polymer is a polyimide. 43. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a polyimide. 44. A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; anda low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a polyimide.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (126)
Blum Rainer (Ludwigshafen DEX) Heller Hans J. (Hamburg DEX) Haehnle Hans-Joachim (Ludwigshafen DEX) Lienert Klaus (Hamburg DEX), Adhesion promoter.
Flaim Tony (St. James MO) Lamb ; III James E. (Rolla MO) Barnes Gregg (Lebanon MO) Brewer Terry (Rolla MO), Base-soluble polyimide release layers for use in microlithographic processing.
Watzke Eckhart,DEX ; Kampfer Andrea,DEX ; Brix Peter,DEX ; Ott Franz,DEX, Borosilicate glass of high chemical resistance and low viscosity which contains zirconium oxide and lithium oxide.
Gleason Karen K. ; Limb Scott J. H. ; Gleason Edward F. ; Sawin Herbert H. ; Edell David J., Chemical vapor deposition of fluorocarbon polymer thin films.
Sommer, Martin; Fabian, Artur; Borens, Manfred; Heinz, Jochen, Closeable glass container comprising a plastic coating applied by injection molding and method for the production thereof.
Izawa, Hajime; Yamamoto, Yuji; Tanaka, Shin-ichi; Wakabayashi, Atsumi; Motoki, Toru; Horikoshi, Hideki, Coating material for forming transparent and conductive film.
Fadeev, Andrei Gennadyevich; Chang, Theresa; Bookbinder, Dana Craig; Pal, Santona; Saha, Chandan Kumar; DeMartino, Steven Edward; Timmons, Christopher Lee; Peanasky, John Stephen; Schaut, Robert Anthony; Danielson, Paul Stephen; Drake, Melinda Ann; Morena, Robert Michael; Adib, Kaveh; Hamilton, James Patrick; Schiefelbein, Susan Lee, Delamination resistant glass containers with heat-tolerant coatings.
Bleile Erwin,DEX ; Geiger Andreas,DEX ; Heinz Jochen,DEX ; Schluter Reinhard,DEX ; Spallek Michael,DEX ; Reinhard Michael,DEX, Glass bottle with a sprayed on synthetic coating, its production process and device necessary for its production.
Jnsson Bo R. (Skyrsta 42 690 43 Hammar SEX) Toll Gunnar G. (Asbacken 7 445 00 Bohus SEX) Bodelind Bo T. K. (Skrddargrnd 20 445 00 Bohus SEX), Glass container with a fixed plastic protective layer.
Ikenishi, Mikio; Morita, Atsuko; Zou, Xuelu, Glass substrate for information recording medium and magnetic information recording medium to which the glass substrate is applied.
Sakaguchi Seiichi,JPX ; Murase Mitsutoshi,JPX, Glazing layer-forming composition for hot-coating of furnace refractories and method of forming glazing layer.
Shoshi Satoru (Saitama-ken JPX) Watanabe Shunpei (Saitama-ken JPX) Saito Takanori (Saitama-ken JPX), Hard coat film having an easily slipping property and process for producing the same.
Brown David Ward ; Baylog Melissa ; Kimock Fred M. ; Knapp Bradley J. ; Petrmichl Rudolph Hugo ; Thear Edward George, Highly wear-resistant thermal print heads with silicon-doped diamond-like carbon protective coatings.
Kennedy Alvin P. (Midland MI) Bratton Larry D. (Lake Jackson TX) Jezie Zdravko (Lake Jackson TX) Lane Eckel R. (Midland MI) Perettie Donald J. (Midland MI) Richey W. Frank (Lake Jackson TX) Babb Davi, Laminates of polymers having perfluorocyclobutane rings and polymers containing perfluorocyclobutane rings.
Wolff Per,DKX ; Larsen Hans-Ole,DKX ; Kamstrup-Larsen J.o slashed.gen,DKX, Medical instrument with a hydrophilic, low-friction coating and method of preparation.
Nozawa Mitsuru (Nagoya JPX) Nomura Makio (Bisai JPX) Takaba Akihiko (Nagoya JPX) Hayashi Masato (Minokamo JPX), Method for manufacturing a glass container having a large impact strength using permanent and non permanent coatings on.
Scholes Addison B. (Muncie IN) Lamirand Joseph (Muncie IN) Saltsgaver Duane (Noblesville IN), Method for the cold end coating of glassware using a vaporizer having an internal flow path from a reservoir of liquid c.
Bradley Ronald W. (Sylvania OH) Carl David G. (Sylvania OH) Keating Bernard L. (Toledo OH), Method of strengthening glass containers and articles so made.
Liu,Yaoqi J.; Sievers,Jerry A.; Ruff,Andrew T., Multilayer infrared reflecting film with high and smooth transmission in visible wavelength region and laminate articles made therefrom.
Effenberger John A. (Bennington VT) Ribbans ; III Robert C. (Bennington VT) Keese Frank M. (Hoosick Falls NY), Novel wear resistant fluoropolymer-containing flexible composites and method for preparation thereof.
Moss Mary G. (Rolla MO) Brewer Terry (Rolla MO) Cuzmar Ruth M. (Rolla MO) Hawley Dan W. (St. James MO) Flaim Tony D. (St. James MO), Positive working polyamic acid/imide photoresist compositions and their use as dielectrics.
Heinz, Jochen; Spallek, Michael, Process and apparatus for applying a thermally attached lubricating coating on an interior wall of a cylindrical container for medicinal purposes.
Andrews George L. (Endicott NY) Bhatt Anilkumar C. (Endicott NY) Doran Donald E. (New Milford PA) Hunsinger Leo E. (Binghamton NY), Process for coating fibers, use thereof, and product.
St. Clair Anne K. (Poquoson VA) St. Clair Terry L. (Poquoson VA), Process for preparing essentially colorless polyimide film containing phenoxy-linked diamines.
St. Clair Anne K. (Poquoson VA) St. Clair Terry L. (Poquoson VA), Process for preparing highly optically transparent/colorless aromatic polyimide film.
Gallagher Patrick E. (Pittsfield MA) Greenberg Ronald A. (Lenox MA), Process for the production of a random copolymer containing repeating polyimide units and repeating polyetherimide units.
Dubois Jean G. (“En Bagatelle”71700 Tournus FRX) Hesling Michel (Rue Raymond Dorey 71700 Tournus FRX), Process for treating glass containers with a protective varnish, and protecting varnish used.
Carre Alain R. E. (Le Chatelet en Brie FRX) Roger Francoise M. M. (Avon FRX), Processes for producing colored glass or glass-ceramic articles bearing a non-stick coating, compositions for carrying o.
Tesoro Giuliana C. (Dobbs Ferry NY) Uhlmann Donald R. (Newton MA) Rajendran Giovindasamy P. (Brooklyn NY) Park Chan E. (Cambridge MA), Silane coupling agents polyimide-mineral oxide composites.
Chang, Theresa; DeMartino, Steven Edward; Fadeev, Andrei Gennadyevich; Peanasky, John Stephen; Schaut, Robert Anthony; Timmons, Christopher Lee, Strengthened borosilicate glass containers with improved damage tolerance.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Johathan R.; Pangborn, Robert J.; Sagona, Peter J., Vessel, coating, inspection and processing apparatus.
Liu, Yaoqi J.; Boettcher, Jeffrey A.; Kranz, Heather K.; Ruff, Andrew T.; Koster, Brian L.; Mortenson, David K., Wrinkle resistant infrared reflecting film and non-planar laminate articles made therefrom.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.